Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Yoni Grossman, Gadi Shlomai & Ehud Grossman. (2014) Treating hypertension in type 2 diabetes. Expert Opinion on Pharmacotherapy 15:15, pages 2131-2140.
Read now
Read now
Carlos Escobar, Rocio Echarri & Vivencio Barrios. (2012) Emerging drug combinations to optimize renovascular protection and blood pressure goals. International Journal of Nephrology and Renovascular Disease 5, pages 69-80.
Read now
Read now
Fabio Angeli, Paolo Verdecchia & Gianpaolo Reboldi. (2012) Intensive blood pressure control in obese diabetic patients: clinical relevance of stroke prevention in the ACCORD trial. Expert Review of Cardiovascular Therapy 10:12, pages 1467-1470.
Read now
Read now
E Van der Merwe & A Carboni. (2011) Strategies to improve blood pressure control and cardiovascular outcomes in hypertensive patients. South African Family Practice 53:6, pages 525-532.
Read now
Read now
Gianpaolo Reboldi, Giorgio Gentile, Fabio Angeli & Paolo Verdecchia. (2009) Exploring the optimal combination therapy in hypertensive patients with diabetes mellitus. Expert Review of Cardiovascular Therapy 7:11, pages 1349-1361.
Read now
Read now
Articles from other publishers (26)
P. Divya Bhargavi, Siddhartha Lolla, Sinoy Sugunan, Kumar Shiva Gubbiyappa, Azmat Ali Khan, Amer M. Alanazi & Bhukya Vijay Nayak. (2023) The simultaneous quantification of Sitagliptin and Irbesartan in rat plasma using the validated LC-MS/MS method is applied to a pharmacokinetic study. Journal of Chromatography B 1221, pages 123677.
Crossref
Crossref
Martina Zappa, Paolo Verdecchia, Antonio Spanevello, Michele Golino & Fabio Angeli. (2023) mRNA Metabolism and Hypertension. Biomedicines 11:1, pages 118.
Crossref
Crossref
Amruta Vidyadhar Yadav & Chandrashekhar Devidas Upasani. (2022) Protective effect of the combination of Hydroalcoholic extracts of Asparagus Racemosus, Centella Asiatica, Plumeria rubra with Glibenclamide in Experimentally Induced Diabetic Nephropathy in rats. Research Journal of Pharmacy and Technology, pages 1614-1620.
Crossref
Crossref
Sergius C. Onwukwe & Nnabuike C. Ngene. (2022) Blood pressure control in hypertensive patients attending a rural community health centre in Gauteng Province, South Africa: A cross-sectional study. South African Family Practice 64:1.
Crossref
Crossref
Paolo Verdecchia, Claudio Cavallini & Fabio Angeli. (2022) Advances in the Treatment Strategies in Hypertension: Present and Future. Journal of Cardiovascular Development and Disease 9:3, pages 72.
Crossref
Crossref
Zhiguo Wang & Baofeng YangZhiguo Wang & Baofeng Yang. 2022. Polypharmacology. Polypharmacology
323
342
.
Ishaq A. Viringipurampeer, Cheryl Y. Gregory-Evans, Andrew L. Metcalfe, Emran Bashar, Orson L. Moritz & Kevin Gregory-Evans. (2018) Cell Death Pathways in Mutant Rhodopsin Rat Models Identifies Genotype-Specific Targets Controlling Retinal Degeneration. Molecular Neurobiology 56:3, pages 1637-1652.
Crossref
Crossref
Marc G. Jaffe, Thomas R. Frieden, Norman R. C. Campbell, Kunihiro Matsushita, Lawrence J. Appel, Daniel T. Lackland, Xin Hua Zhang, Arumugam Muruganathan & Paul K. Whelton. (2018) Recommended treatment protocols to improve management of hypertension globally: A statement by Resolve to Save Lives and the World Hypertension League (WHL). The Journal of Clinical Hypertension 20:5, pages 829-836.
Crossref
Crossref
Alon Grossman & Ehud Grossman. (2017) Blood pressure control in type 2 diabetic patients. Cardiovascular Diabetology 16:1.
Crossref
Crossref
Jie Zhang, Helena Y. Qu, Jiangping Song, Jin Wei, Shan Jiang, Lei Wang, Liqing Wang, Jacentha Buggs & Ruisheng Liu. (2017) Enhanced hemodynamic responses to angiotensin II in diabetes are associated with increased expression and activity of AT1 receptors in the afferent arteriole. Physiological Genomics 49:10, pages 531-540.
Crossref
Crossref
Maria Aslam, Mobasher Ahmad & Fizza Mobasher. (2017) Efficacy and tolerability of antihypertensive drugs in diabetic and nondiabetic patients. Journal of Pharmacy And Bioallied Sciences 9:1, pages 56.
Crossref
Crossref
Ricardo Bedirian, Mario Fritsch Neves, Wille Oigman, Ronaldo Altenburg Odebrecht Curi Gismondi, Cesar Romaro Pozzobon, Marcia Cristina Boaventura Ladeira & Marcia Bueno Castier. (2016) Correlation between Diastolic Function and Endothelial Function in Patients with Type 2 Diabetes and Hypertension. The Open Cardiovascular Medicine Journal 10:1, pages 212-220.
Crossref
Crossref
Fabio Angeli, Gianpaolo Reboldi, Cristina Poltronieri, Ludovico Lazzari, Martina Sordi, Marta Garofoli, Claudia Bartolini & Paolo Verdecchia. (2015) Hyperglycemia in acute coronary syndromes: from mechanisms to prognostic implications. Therapeutic Advances in Cardiovascular Disease 9:6, pages 412-424.
Crossref
Crossref
Fabio Angeli, Gianpaolo Reboldi & Paolo Verdecchia. (2014) Hypertension, inflammation and atrial fibrillation. Journal of Hypertension 32:3, pages 480-483.
Crossref
Crossref
Mervat E. Mohamed. (2014) Can Sitaglipten Attenuate Hypertension, Myocardial Changes and Vascular Reactivity Induced by Long Term Blockade of Nitric Oxide Synthesis in the Rat?. Open Journal of Endocrine and Metabolic Diseases 04:07, pages 197-210.
Crossref
Crossref
Nasreen A. Al-Sayed, Tianming Gao, Brian J. Wells, Changhong Yu & Robert S. Zimmerman. (2013) Angiotensin-Converting Enzyme Inhibitors Reduce Albuminuria More than Angiotensin Receptor Blockers in Patients with Type 2 Diabetes. Endocrine Practice 19:4, pages 579-586.
Crossref
Crossref
Fabio Angeli, Gianpaolo Reboldi & Paolo Verdecchia. (2013) Hypertension around the world. Journal of Hypertension 31:7, pages 1358-1361.
Crossref
Crossref
David J. Taber, Holly B. Meadows, Nicole A. Pilch, Kenneth D. Chavin, Prabhakar K. Baliga & Leonard E. Egede. (2013) Pre-existing diabetes significantly increases the risk of graft failure and mortality following renal transplantation. Clinical Transplantation 27:2, pages 274-282.
Crossref
Crossref
Raymond R. Townsend, Alan D. Forker, Vaishali Bhosekar, Anthony Yadao & Deborah L. Keefe. (2011) Comparison of Aliskiren/Hydrochlorothiazide Combination Therapy and Amlodipine Monotherapy in Patients With Stage 2 Systolic Hypertension and Type 2 Diabetes Mellitus. The Journal of Clinical Hypertension 13:12, pages 889-897.
Crossref
Crossref
Gianpaolo Reboldi, Giorgio Gentile, Fabio Angeli & Paolo Verdecchia. (2011) Optimal Therapy in Hypertensive Subjects with Diabetes Mellitus. Current Atherosclerosis Reports 13:2, pages 176-185.
Crossref
Crossref
Joseph T. Flynn. 2011. Pediatric Hypertension. Pediatric Hypertension
329
342
.
Que Liu, Lisa Adams, Anatoly Broyde, Rayne Fernandez, Alain D Baron & David G Parkes. (2010) The exenatide analogue AC3174 attenuates hypertension, insulin resistance, and renal dysfunction in Dahl salt-sensitive rats. Cardiovascular Diabetology 9:1.
Crossref
Crossref
Claudio Borghi & Arrigo F. G. Cicero. (2012) Rationale for the Use of a Fixed-Dose Combination in the Management of Hypertension. Clinical Drug Investigation 30:12, pages 843-854.
Crossref
Crossref
Daniel T. Lackland. (2010) The Role of Combination Therapy for Hypertension After ACCOMPLISH. Current Cardiovascular Risk Reports 4:4, pages 251-255.
Crossref
Crossref
Nicholas J. Van Sickels, Robert B. Hunsaker & Joseph E. Van Sickels. (2010) Hereditary angioedema: treatment, management, and precautions in patients presenting for dental care. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology 109:2, pages 168-172.
Crossref
Crossref
Bertram Pitt. (2010) The Role of Aldosterone Blockade in Patients with Hypertensive Heart and Cardiovascular Disease. Clinical Medicine Insights: Therapeutics 2, pages CMT.S2232.
Crossref
Crossref